Eris Lifesciences Limited (ERIS) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE406M01024
Key metrics
- Market Cap
- ₹18,376 Cr
- P/E Ratio
- 28.26
- EPS
- 46.92
- Book Value
- 281.19
- P/B Ratio
- 4.72
- ROE
- 15.9%
- ROCE
- 13.44%
- Debt / Equity
- 0.61
- Net Margin
- 19.89%
- Revenue Growth
- 8.18%
- Profit Growth
- 76.07%
- Dividend Yield
- 1.07%
- 52W High
- ₹1,818.80
- 52W Low
- ₹1,200.00
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Eris Lifesciences Limited
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 69.92%
The full Eris Lifesciences Limited analysis
Create a free account to open the complete ERIS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.